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INTRODUCTION 
It is known that medications degrade over time, and that extreme storage conditions will hasten their degradation. 
The temperature and humidity conditions of the ISS have been shown to be within the ideal ranges for medication 
storage, but the effects of other environmental factors, like elevated exposure to radiation, have not yet been 
evaluated. Current operational procedures ensure that ISS medications are re-stocked before expiration, but this may 
not be possible on long duration exploration missions. For this reason, medications that have experienced long 
duration storage on the ISS were returned to JSC for analysis to determine any unusual effects of aging in the low-
Earth orbit environment.  
 
METHODS 
Medications were obtained by the JSC Pharmacy from commercial distributors and  were re-packaged by JSC 
pharmacists to conserve up mass and volume. All medication doses were part of the ISS crew medical kit and were 
transported to the International Space Station (ISS) via NASA’s Shuttle Transportation System (Space Shuttle). 
After 568 days of storage, the medications were removed from the supply chain and returned to Earth on a Dragon 
(SpaceX) capsule. Upon return to Earth, medications were transferred to temperature and humidity controlled 
environmental chambers until analysis.  
 
Nine medications were chosen on the basis of their availability for study. The medications included several of the 
most heavily used by US crewmembers: 2 sleep aids, 2 antihistamines/decongestants, 3 pain relievers, an 
antidiarrheal and an alertness medication. Each medication was available at a single time point; analysis of the same 
medication at multiple time points was not possible. Because the samples examined in this study were obtained 
opportunistically from medical supplies, there were no control samples available (i.e. samples aged for a similar 
period of time on the ground); a significant limitation of this study. Medications were analyzed using the HPLC/MS 
methods described in the United States Pharmacopeia (USP) to measure the amount of intact active ingredient, 
identify degradation products and measure their amounts. Some analyses were conducted by an independent 
analytical laboratory, but certain (Schedule) medications could not be shipped to their facility and were analyzed at 
JSC. 
  
RESULTS 
Nine medications were analyzed with respect to active pharmaceutical ingredient (API) and degradant amounts. 
Results were compared to the USP requirements for API and degradants/impurities content for every FDA-approved 
medication. One medication met USP requirements at 5 months after its expiration date. Four of the nine (44% of 
those tested) medications tested met USP requirements up to 8 months post-expiration. Another 3 medications (33% 
of those tested) met USP guidelines 2-3 months before expiration. One medication, a compound classed by the FDA 
as a dietary supplement and sometimes used as a sleep aid, failed to meet USP requirements at 11 months post-
expiration.  
 
CONCLUSION 
Analysis of each medication at a single time point provides limited information on the stability of a medication 
stored in particular conditions; it is not possible to predict how long a medication may be safe and effective from 
these data. Notwithstanding, five of the nine medications tested (56%) met USP requirements for API and 
degradants/impurities at least 5 months past expiration dates. The single compound that failed to meet USP 
requirements is not regulated as strictly as prescription medications are during manufacture; it is unknown if this 
medication would have met the requirements prior to flight. Notably, it was the furthest beyond its expiration date.  
Only more comprehensive analysis of flight-aged samples compared to appropriate ground controls will permit 
determination of spaceflight effects on medication stability.  
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